NCT02659618View on ClinicalTrials.gov

Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma

CompletedOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 26, 2018

Study Completion Date

December 16, 2020

Conditions

Severe Persistent Asthma

Trial Locations (1)

60612

University Consultants in Allergy/Immunology, Chicago

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Rush University Medical Center

OTHER